Literature DB >> 29653723

Characterization of the duodenal bacterial microbiota in patients with pancreatic head cancer vs. healthy controls.

Qi-Xiang Mei1, Chun-Lan Huang1, Sheng-Zheng Luo1, Xue-Mei Zhang2, Yue Zeng3, Ying-Ying Lu4.   

Abstract

An increasing number of reports have demonstrated that there is an association between the presence of pathogenic microorganisms and pancreatic cancer. However, the role of the duodenal microbiota in pancreatic carcinogenesis remains unknown. In this study, duodenal mucosal microbiota was analyzed in 14 patients with pancreatic head cancer and 14 healthy controls using 16S rRNA gene pyrosequencing methods. Plasma endotoxin activity and the concentrations of the proinflammatory cytokine IL-6 and C-reactive protein (CRP) were measured in blood samples. The urea breath test was used to detect Helicobacter pylori infections. Endoscopic duodenal mucosal biopsies were evaluated by histological examinations. Statistical comparisons of inflammatory factors revealed significantly higher levels of CRP and IL-6 in the pancreatic cancer group as compared to healthy controls. Patients with pancreatic cancer also had a higher incidence of H. pylori infections and showed mucosal changes, including villous abnormalities and diffuse inflammatory cell infiltration in the lamina propria. The sequences analysis showed that based on linear discriminant analysis effect size (LEfSe) analysis at the genus level, Acinetobacter, Aquabacterium, Oceanobacillus, Rahnella, Massilia, Delftia, Deinococcus, and Sphingobium were more abundant in the duodenal mucosa of pancreatic cancer patients, whereas the duodenal microbiotas of healthy controls were enriched with Porphyromonas, Paenibacillus, Enhydrobacter, Escherichia, Shigella, and Pseudomonas. These results reveal a picture of duodenal microbiota in pancreatic head cancer patients that could be useful in future trials investigating the role of gut microbiota in pancreatic cancer.
Copyright © 2018 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Duodenal microbiota; Intestinal inflammation; Pancreatic head cancer

Mesh:

Substances:

Year:  2018        PMID: 29653723     DOI: 10.1016/j.pan.2018.03.005

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  25 in total

1.  Uncovering the microbiota in renal cell carcinoma tissue using 16S rRNA gene sequencing.

Authors:  Junpeng Wang; Xin Li; Xiaoqiang Wu; Zhiwei Wang; Chan Zhang; Guanghui Cao; Kangdong Liu; Tianzhong Yan
Journal:  J Cancer Res Clin Oncol       Date:  2020-11-21       Impact factor: 4.553

2.  Alterations in the Duodenal Fluid Microbiome of Patients With Pancreatic Cancer.

Authors:  Shiro Kohi; Anne Macgregor-Das; Mohamad Dbouk; Takeichi Yoshida; Miguel Chuidian; Toshiya Abe; Michael Borges; Anne Marie Lennon; Eun Ji Shin; Marcia Irene Canto; Michael Goggins
Journal:  Clin Gastroenterol Hepatol       Date:  2020-11-05       Impact factor: 11.382

3.  A faecal microbiota signature with high specificity for pancreatic cancer.

Authors:  Ece Kartal; Thomas S B Schmidt; Esther Molina-Montes; Sandra Rodríguez-Perales; Jakob Wirbel; Oleksandr M Maistrenko; Wasiu A Akanni; Bilal Alashkar Alhamwe; Renato J Alves; Alfredo Carrato; Hans-Peter Erasmus; Lidia Estudillo; Fabian Finkelmeier; Anthony Fullam; Anna M Glazek; Paulina Gómez-Rubio; Rajna Hercog; Ferris Jung; Stefanie Kandels; Stephan Kersting; Melanie Langheinrich; Mirari Márquez; Xavier Molero; Askarbek Orakov; Thea Van Rossum; Raul Torres-Ruiz; Anja Telzerow; Konrad Zych; Vladimir Benes; Georg Zeller; Jonel Trebicka; Francisco X Real; Nuria Malats; Peer Bork
Journal:  Gut       Date:  2022-03-08       Impact factor: 31.793

4.  Tongue coating microbiome data distinguish patients with pancreatic head cancer from healthy controls.

Authors:  Haifeng Lu; Zhigang Ren; Ang Li; Jinyou Li; Shaoyan Xu; Hua Zhang; Jianwen Jiang; Jiezuan Yang; Qixia Luo; Kai Zhou; Shusen Zheng; Lanjuan Li
Journal:  J Oral Microbiol       Date:  2019-01-28       Impact factor: 5.474

5.  Microbial Community Analysis of Saliva and Biopsies in Patients With Oral Lichen Planus.

Authors:  Xuewei Wang; Zhibai Zhao; Nan Tang; Yuping Zhao; Juanyong Xu; Liuyang Li; Ling Qian; Junfeng Zhang; Yuan Fan
Journal:  Front Microbiol       Date:  2020-05-05       Impact factor: 5.640

Review 6.  Oncobiosis and Microbial Metabolite Signaling in Pancreatic Adenocarcinoma.

Authors:  Borbála Kiss; Edit Mikó; Éva Sebő; Judit Toth; Gyula Ujlaki; Judit Szabó; Karen Uray; Péter Bai; Péter Árkosy
Journal:  Cancers (Basel)       Date:  2020-04-25       Impact factor: 6.639

Review 7.  The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer.

Authors:  Rossella Cianci; Laura Franza; Giovanni Schinzari; Ernesto Rossi; Gianluca Ianiro; Giampaolo Tortora; Antonio Gasbarrini; Giovanni Gambassi; Giovanni Cammarota
Journal:  Int J Mol Sci       Date:  2019-01-24       Impact factor: 5.923

Review 8.  Pancreatic Cancer, Gut Microbiota, and Therapeutic Efficacy.

Authors:  Xiang Zhang; Qiaofei Liu; Quan Liao; Yupei Zhao
Journal:  J Cancer       Date:  2020-02-20       Impact factor: 4.207

Review 9.  Role of the microbiome in occurrence, development and treatment of pancreatic cancer.

Authors:  Yicheng Wang; Gang Yang; Lei You; Jinshou Yang; Mengyu Feng; Jiangdong Qiu; Fangyu Zhao; Yueze Liu; Zhe Cao; Lianfang Zheng; Taiping Zhang; Yupei Zhao
Journal:  Mol Cancer       Date:  2019-12-01       Impact factor: 27.401

10.  The effects of exopolysaccharides and exopolysaccharide-producing Lactobacillus on the intestinal microbiome of zebrafish (Danio rerio).

Authors:  Chenchen Ma; Hongyang Guo; Haibo Chang; Shi Huang; Shuaiming Jiang; Dongxue Huo; Jiachao Zhang; Xiaopeng Zhu
Journal:  BMC Microbiol       Date:  2020-10-06       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.